Patent 11903984 was granted and assigned to Phi Therapeutics on February, 2024 by the United States Patent and Trademark Office.
Provided herein are, inter alia, compositions, systems, and methods for preventing or treating acne. Included are compositions, combinations, systems, and methods comprising at least one